MedTrace Logo

Building a Database of Results From People Without Eye Problems

NCT02627339 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 208

Last updated 2016-11-21

No results posted yet for this study

Summary

The purpose of this study is to build a database of results from a new test that measures contrast sensitivity (the Spaeth-Richman Contrast Sensitivity Test (SPARCS)). Contrast sensitivity is an important part of your ability to see. When contrast sensitivity decreases, you are less able to see objects and detect motion. For instance, if you have decreased contrast sensitivity, you might be less able to read, see in the dark, drive, hit a ball, or walk safely. Decrease in contrast sensitivity leads to a decrease in quality of life.

Conditions

Sponsors & Collaborators

  • Partridge Foundation

    collaborator UNKNOWN

  • Wills Eye

    lead OTHER

Principal Investigators

  • George L Spaeth, MD · Medical Director, Glaucoma Research Center

Eligibility

Min Age
10 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-08-31
Primary Completion
2015-08-31
Completion
2015-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02627339 on ClinicalTrials.gov